|
|
|
A Partial Index to Articles that have Appeared in ESUN by Bruce D. Shriver, PhD Editor-in-Chief, ESUN ESUN is now in its fourth year. We have received many requests to produce an annual index for it. Given the current development tools that we are using to produce ESUN and to build and maintain our website, this is a difficult manual task. We will be making a move in the autumn to new development environment in which this will be an automated task and one in which, as a side-effect, each article will be downloadable in Adobe's PDF format. Until this is done (which will be a multi-month project after it is initiated), we are providing the following “partial index” of feature articles listed in alphabetical order by title in three categories: 1. DETAILED ARTICLES ABOUT SPECIFIC SARCOMAS 2. ARTICLES OF GENERAL INTEREST 3. OPINION PIECES Because there are literally hundreds of items and abstracts in the “Clinical Trail News”, “Odds & Ends”, “Research Corner” and "Stories of Courage and Hope" columns, we do not include them in the partial index below. We hope to provide a general search facility after our move to the new technology base is complete.
DETAILED ARTICLES ABOUT SPECIFIC SARCOMAS by James M. Lewis, MD and Vernon K. Sondak, MD
by R. Lor Randall, MD and Kenneth J. Hunt, MD
Clear Cell Sarcoma and Alveolar Soft Part Sarcoma by John M. Goldberg, MD and Karen Albritton, MD
Cytarabine for the Treatment of Ewing's Sarcoma by Steven G. DuBois, MD, Holcombe E. Grier, MD, and Kimberly Stegmaier, MD
Ewing’s Sarcoma Family of Tumors (ESFT) by R. Lor Randall, MD
Leiomyosarcoma of Bone and Soft Tissue: A Review by Michael J. Weaver, MD and John A. Abraham, MD
Leiomyosarcoma of the Uterus: A Review by Sue Ghosh, MD, Jonathan L. Hecht, MD, PhD, Tanaz R. Ferzandi, MD, MA, and Christopher S. Awtrey, MD
by Mark C. Gebhardt, MD and Peter J. Buecker, MD
Malignant Fibrous Histiocytoma (MFH) by Carol D. Morris, MD
Malignant Peripheral Nerve Sheath Tumors (MPNST) by David S. Geller, MD and Mark C. Gebhardt, MD
by John M. Goldberg, MD and Holcombe Grier, MD
Novel Approaches for the Molecular Targeting of Ewing's Sarcoma Family of Tumors by Silke Schlottmann, PhD and Jeffrey A. Toretsky, MD
by Peter J. Buecker, MD and Mark C. Gebhardt, MD
Osteosarcoma: A Practitioner's Quick Reference Guide by Lindy Eddinger
by Julia D. Royster, PhD
by Leonard H. Wexler, MD
by Andrea Ferrari, MD and Paola Collini, MD
ARTICLES OF GENERAL INTEREST Adolescent and Young Adult Cancer Care by Karen Albritton, MD
An Overview of Some Recent Cancer-Related Nanotechnology Research by Bruce Shriver, PhD
AP23573: A Review of Recent Results by Sant P. Chawla, MD, Kamalesh Sankhala, MD, Monica Mita, MD and Anthony W. Tolcher, MD
by Lindsay Nohr Beck, Kutluk Oktay, MD and Peter N. Schlegel, MD
Chemotherapy for Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Childhood: To Treat or Not to Treat? by Crystal Mackall, MD
Chromosomal Translocations in Sarcomas: New Perspectives by Gabriela E. Mercado, MD and Frederic G. Barr, MD
Clinical Trials in Bone Sarcomas by Richard Gorlick, MD
by Denise Reinke, APRN, BC, AOCN
Correlation of Lack of Participation on Clinical Trials and Lack of Progress in Bone Sarcoma by Archie Bleyer, MD
by Bruce and Beverly Shriver
ET-743: A Review of Recent Results by Margaret von Mehren, MD
For Metastases—All Sarcomas are Not Created Equal by Crystal Mackall, MD
From Easter Island Soil to Treating Sarcoma—Rapamycin Derivatives by Danny McGurl
Gene Profiling Studies on Sarcomas by Matt van de Rijn, MD
Gene Profiling: Unlocking the Inner Workings of Sarcoma Cells by Crystal Mackall MD and Javed Khan MD
On the Horizon: Gene and Virus Therapies for Sarcomas by Timothy P. Cripe, MD, PhD
Options and Follow-up Care for Women with Uterine Sarcomas by Suzie Siegel
Salvage of the Unplanned Sarcoma Excision by Peter J. Buecker, MD
The COG Survivor Guidelines: A View from the Pediatric Sarcoma Perspective by Joan Darling, PhD
The Wall of Fame - A Sarcoma Survivor Project by Tamara Barnes, RN, MSN, CNS, AOCN
OPINION PIECES A Rose is a Rose or a Thorn is a Thorn by Laurence Baker, DO
Are there - or should there be - pediatric sarcoma centers? by Joan Darling, PhD
CTOS Op Ed Pieces Prof. Ian Judson, MD, FRCP
by R. Lor Randall, MD
There is no reason to include age as an entry criterion for any clinical trial By Paul A. Myers, MD
Guidelines for Patients and Caregivers by Murray F. Brennan, MD
by Murray F. Brennan, MD
by Murray F. Brennan, MD
Lobbying for the "Exceptionally Rare Diseases and Conditions Act" - a unique pathway for new drugs for sarcoma patients by Mark Thornton, MD
Sarcoma: A Diagnosis of Patience by Peter J. Buecker, MD
Soft Tissue Sarcoma – One physician’s Viewpoint by Murray F. Brennan, MD
by Bruce Shriver, PhD
The Shocking State of NCI Funding by Joan Darling, PhD
by Deborah Buks |